The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Protein Therapeutics Drugs Market Research Report 2025
Synopsis
Protein Therapeutics Drugs are a type of medicine that are used to treat a variety of diseases such as cancer, metabolic, immunological, hematological, hormonal, genetic, infectious diseases, and others. These drugs have the potential to significantly improve human health. In principle, protein therapy is similar to gene therapy; which involves protein delivery in specific amounts to the body to facilitate precise functioning of different glands and other organs in the body
The global Protein Therapeutics Drugs market was valued at US$ 291000 million in 2023 and is anticipated to reach US$ 480750 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Growth of the protein therapeutics market is majorly driven by rise in prevalence of chronic diseases and development of plasma-derived therapies. Increase in prevalence of various diseases such as cancer, metabolic disorders, genetic disorders, and immunological diseases are expected to propel demand for protein therapeutics. In addition, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and cancer cases are expected to increase significantly in the future. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Protein Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Therapeutics Drugs.
The Protein Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Protein Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Protein Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson and Johnson
Pfizer Inc
F. Hoffmann La Roche Ltd
Novo Nordisk AS
Sanofi
Amgen Inc
Merck and Co., Inc
Abbott Laboratories
Baxter International Inc
Eli Lilly And Company
AbbVie
Novartis
Gilead Sciences
Bristol-Myers Squibb
Innovent
AstraZeneca
Hengrui Medicine
Takeda
Kanghong Pharma
Seagen
Sobi
Segment by Type
Monoclonal Antibodies
Insulin
Fusion Protein
Erythropoietin
Interferon
Human Growth Hormone
Others
Segment by Application
Cancer
Metabolic Disorders
Immunologic Disorders
Hematological Disorders
Hormonal Disorders
Genetic Disorders
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Protein Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Protein Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Protein Therapeutics Drugs are a type of medicine that are used to treat a variety of diseases such as cancer, metabolic, immunological, hematological, hormonal, genetic, infectious diseases, and others. These drugs have the potential to significantly improve human health. In principle, protein therapy is similar to gene therapy; which involves protein delivery in specific amounts to the body to facilitate precise functioning of different glands and other organs in the body
The global Protein Therapeutics Drugs market was valued at US$ 291000 million in 2023 and is anticipated to reach US$ 480750 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Growth of the protein therapeutics market is majorly driven by rise in prevalence of chronic diseases and development of plasma-derived therapies. Increase in prevalence of various diseases such as cancer, metabolic disorders, genetic disorders, and immunological diseases are expected to propel demand for protein therapeutics. In addition, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and cancer cases are expected to increase significantly in the future. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Protein Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Therapeutics Drugs.
The Protein Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Protein Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Protein Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson and Johnson
Pfizer Inc
F. Hoffmann La Roche Ltd
Novo Nordisk AS
Sanofi
Amgen Inc
Merck and Co., Inc
Abbott Laboratories
Baxter International Inc
Eli Lilly And Company
AbbVie
Novartis
Gilead Sciences
Bristol-Myers Squibb
Innovent
AstraZeneca
Hengrui Medicine
Takeda
Kanghong Pharma
Seagen
Sobi
Segment by Type
Monoclonal Antibodies
Insulin
Fusion Protein
Erythropoietin
Interferon
Human Growth Hormone
Others
Segment by Application
Cancer
Metabolic Disorders
Immunologic Disorders
Hematological Disorders
Hormonal Disorders
Genetic Disorders
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Protein Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Protein Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Protein Therapeutics Drugs Market Overview
1.1 Product Definition
1.2 Protein Therapeutics Drugs by Type
1.2.1 Global Protein Therapeutics Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Fusion Protein
1.2.5 Erythropoietin
1.2.6 Interferon
1.2.7 Human Growth Hormone
1.2.8 Others
1.3 Protein Therapeutics Drugs by Application
1.3.1 Global Protein Therapeutics Drugs Market Value by Application (2024-2030)
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Immunologic Disorders
1.3.5 Hematological Disorders
1.3.6 Hormonal Disorders
1.3.7 Genetic Disorders
1.3.8 Others
1.4 Global Protein Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Protein Therapeutics Drugs Revenue 2019-2030
1.4.2 Global Protein Therapeutics Drugs Sales 2019-2030
1.4.3 Global Protein Therapeutics Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Protein Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Protein Therapeutics Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Protein Therapeutics Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Protein Therapeutics Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Protein Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Protein Therapeutics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Protein Therapeutics Drugs, Product Type & Application
2.7 Global Key Manufacturers of Protein Therapeutics Drugs, Date of Enter into This Industry
2.8 Global Protein Therapeutics Drugs Market Competitive Situation and Trends
2.8.1 Global Protein Therapeutics Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Protein Therapeutics Drugs Players Market Share by Revenue
2.8.3 Global Protein Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Protein Therapeutics Drugs Market Scenario by Region
3.1 Global Protein Therapeutics Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Protein Therapeutics Drugs Sales by Region: 2019-2030
3.2.1 Global Protein Therapeutics Drugs Sales by Region: 2019-2024
3.2.2 Global Protein Therapeutics Drugs Sales by Region: 2025-2030
3.3 Global Protein Therapeutics Drugs Revenue by Region: 2019-2030
3.3.1 Global Protein Therapeutics Drugs Revenue by Region: 2019-2024
3.3.2 Global Protein Therapeutics Drugs Revenue by Region: 2025-2030
3.4 North America Protein Therapeutics Drugs Market Facts & Figures by Country
3.4.1 North America Protein Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Protein Therapeutics Drugs Sales by Country (2019-2030)
3.4.3 North America Protein Therapeutics Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Protein Therapeutics Drugs Market Facts & Figures by Country
3.5.1 Europe Protein Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Protein Therapeutics Drugs Sales by Country (2019-2030)
3.5.3 Europe Protein Therapeutics Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Protein Therapeutics Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Protein Therapeutics Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Protein Therapeutics Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific Protein Therapeutics Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Protein Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Latin America Protein Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Protein Therapeutics Drugs Sales by Country (2019-2030)
3.7.3 Latin America Protein Therapeutics Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Protein Therapeutics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Protein Therapeutics Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Protein Therapeutics Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Protein Therapeutics Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Protein Therapeutics Drugs Sales by Type (2019-2030)
4.1.1 Global Protein Therapeutics Drugs Sales by Type (2019-2024)
4.1.2 Global Protein Therapeutics Drugs Sales by Type (2025-2030)
4.1.3 Global Protein Therapeutics Drugs Sales Market Share by Type (2019-2030)
4.2 Global Protein Therapeutics Drugs Revenue by Type (2019-2030)
4.2.1 Global Protein Therapeutics Drugs Revenue by Type (2019-2024)
4.2.2 Global Protein Therapeutics Drugs Revenue by Type (2025-2030)
4.2.3 Global Protein Therapeutics Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Protein Therapeutics Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Protein Therapeutics Drugs Sales by Application (2019-2030)
5.1.1 Global Protein Therapeutics Drugs Sales by Application (2019-2024)
5.1.2 Global Protein Therapeutics Drugs Sales by Application (2025-2030)
5.1.3 Global Protein Therapeutics Drugs Sales Market Share by Application (2019-2030)
5.2 Global Protein Therapeutics Drugs Revenue by Application (2019-2030)
5.2.1 Global Protein Therapeutics Drugs Revenue by Application (2019-2024)
5.2.2 Global Protein Therapeutics Drugs Revenue by Application (2025-2030)
5.2.3 Global Protein Therapeutics Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Protein Therapeutics Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Company Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson and Johnson Protein Therapeutics Drugs Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 Pfizer Inc
6.2.1 Pfizer Inc Company Information
6.2.2 Pfizer Inc Description and Business Overview
6.2.3 Pfizer Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Inc Protein Therapeutics Drugs Product Portfolio
6.2.5 Pfizer Inc Recent Developments/Updates
6.3 F. Hoffmann La Roche Ltd
6.3.1 F. Hoffmann La Roche Ltd Company Information
6.3.2 F. Hoffmann La Roche Ltd Description and Business Overview
6.3.3 F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Product Portfolio
6.3.5 F. Hoffmann La Roche Ltd Recent Developments/Updates
6.4 Novo Nordisk AS
6.4.1 Novo Nordisk AS Company Information
6.4.2 Novo Nordisk AS Description and Business Overview
6.4.3 Novo Nordisk AS Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novo Nordisk AS Protein Therapeutics Drugs Product Portfolio
6.4.5 Novo Nordisk AS Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi Protein Therapeutics Drugs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Amgen Inc
6.6.1 Amgen Inc Company Information
6.6.2 Amgen Inc Description and Business Overview
6.6.3 Amgen Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amgen Inc Protein Therapeutics Drugs Product Portfolio
6.6.5 Amgen Inc Recent Developments/Updates
6.7 Merck and Co., Inc
6.7.1 Merck and Co., Inc Company Information
6.7.2 Merck and Co., Inc Description and Business Overview
6.7.3 Merck and Co., Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Merck and Co., Inc Protein Therapeutics Drugs Product Portfolio
6.7.5 Merck and Co., Inc Recent Developments/Updates
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Company Information
6.8.2 Abbott Laboratories Description and Business Overview
6.8.3 Abbott Laboratories Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abbott Laboratories Protein Therapeutics Drugs Product Portfolio
6.8.5 Abbott Laboratories Recent Developments/Updates
6.9 Baxter International Inc
6.9.1 Baxter International Inc Company Information
6.9.2 Baxter International Inc Description and Business Overview
6.9.3 Baxter International Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Baxter International Inc Protein Therapeutics Drugs Product Portfolio
6.9.5 Baxter International Inc Recent Developments/Updates
6.10 Eli Lilly And Company
6.10.1 Eli Lilly And Company Company Information
6.10.2 Eli Lilly And Company Description and Business Overview
6.10.3 Eli Lilly And Company Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Eli Lilly And Company Protein Therapeutics Drugs Product Portfolio
6.10.5 Eli Lilly And Company Recent Developments/Updates
6.11 AbbVie
6.11.1 AbbVie Company Information
6.11.2 AbbVie Description and Business Overview
6.11.3 AbbVie Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AbbVie Protein Therapeutics Drugs Product Portfolio
6.11.5 AbbVie Recent Developments/Updates
6.12 Novartis
6.12.1 Novartis Company Information
6.12.2 Novartis Description and Business Overview
6.12.3 Novartis Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novartis Protein Therapeutics Drugs Product Portfolio
6.12.5 Novartis Recent Developments/Updates
6.13 Gilead Sciences
6.13.1 Gilead Sciences Company Information
6.13.2 Gilead Sciences Description and Business Overview
6.13.3 Gilead Sciences Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Gilead Sciences Protein Therapeutics Drugs Product Portfolio
6.13.5 Gilead Sciences Recent Developments/Updates
6.14 Bristol-Myers Squibb
6.14.1 Bristol-Myers Squibb Company Information
6.14.2 Bristol-Myers Squibb Description and Business Overview
6.14.3 Bristol-Myers Squibb Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bristol-Myers Squibb Protein Therapeutics Drugs Product Portfolio
6.14.5 Bristol-Myers Squibb Recent Developments/Updates
6.15 Innovent
6.15.1 Innovent Company Information
6.15.2 Innovent Description and Business Overview
6.15.3 Innovent Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Innovent Protein Therapeutics Drugs Product Portfolio
6.15.5 Innovent Recent Developments/Updates
6.16 AstraZeneca
6.16.1 AstraZeneca Company Information
6.16.2 AstraZeneca Description and Business Overview
6.16.3 AstraZeneca Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.16.4 AstraZeneca Protein Therapeutics Drugs Product Portfolio
6.16.5 AstraZeneca Recent Developments/Updates
6.17 Hengrui Medicine
6.17.1 Hengrui Medicine Company Information
6.17.2 Hengrui Medicine Description and Business Overview
6.17.3 Hengrui Medicine Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hengrui Medicine Protein Therapeutics Drugs Product Portfolio
6.17.5 Hengrui Medicine Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Company Information
6.18.2 Takeda Description and Business Overview
6.18.3 Takeda Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Takeda Protein Therapeutics Drugs Product Portfolio
6.18.5 Takeda Recent Developments/Updates
6.19 Kanghong Pharma
6.19.1 Kanghong Pharma Company Information
6.19.2 Kanghong Pharma Description and Business Overview
6.19.3 Kanghong Pharma Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Kanghong Pharma Protein Therapeutics Drugs Product Portfolio
6.19.5 Kanghong Pharma Recent Developments/Updates
6.20 Seagen
6.20.1 Seagen Company Information
6.20.2 Seagen Description and Business Overview
6.20.3 Seagen Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Seagen Protein Therapeutics Drugs Product Portfolio
6.20.5 Seagen Recent Developments/Updates
6.21 Sobi
6.21.1 Sobi Company Information
6.21.2 Sobi Description and Business Overview
6.21.3 Sobi Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Sobi Protein Therapeutics Drugs Product Portfolio
6.21.5 Sobi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Protein Therapeutics Drugs Industry Chain Analysis
7.2 Protein Therapeutics Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Protein Therapeutics Drugs Production Mode & Process
7.4 Protein Therapeutics Drugs Sales and Marketing
7.4.1 Protein Therapeutics Drugs Sales Channels
7.4.2 Protein Therapeutics Drugs Distributors
7.5 Protein Therapeutics Drugs Customers
8 Protein Therapeutics Drugs Market Dynamics
8.1 Protein Therapeutics Drugs Industry Trends
8.2 Protein Therapeutics Drugs Market Drivers
8.3 Protein Therapeutics Drugs Market Challenges
8.4 Protein Therapeutics Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Protein Therapeutics Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Protein Therapeutics Drugs Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Protein Therapeutics Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Protein Therapeutics Drugs Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Protein Therapeutics Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Protein Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Protein Therapeutics Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Protein Therapeutics Drugs Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Protein Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Protein Therapeutics Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Protein Therapeutics Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Protein Therapeutics Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Protein Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Therapeutics Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Protein Therapeutics Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Protein Therapeutics Drugs Sales by Region (2019-2024) & (K Dose)
Table 18. Global Protein Therapeutics Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Protein Therapeutics Drugs Sales by Region (2025-2030) & (K Dose)
Table 20. Global Protein Therapeutics Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Protein Therapeutics Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Protein Therapeutics Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Protein Therapeutics Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Protein Therapeutics Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Protein Therapeutics Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Protein Therapeutics Drugs Sales by Country (2019-2024) & (K Dose)
Table 27. North America Protein Therapeutics Drugs Sales by Country (2025-2030) & (K Dose)
Table 28. North America Protein Therapeutics Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Protein Therapeutics Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Protein Therapeutics Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Protein Therapeutics Drugs Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Protein Therapeutics Drugs Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Protein Therapeutics Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Protein Therapeutics Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Protein Therapeutics Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Protein Therapeutics Drugs Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Protein Therapeutics Drugs Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Protein Therapeutics Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Protein Therapeutics Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Protein Therapeutics Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Protein Therapeutics Drugs Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Protein Therapeutics Drugs Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Protein Therapeutics Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Protein Therapeutics Drugs Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Protein Therapeutics Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Protein Therapeutics Drugs Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East and Africa Protein Therapeutics Drugs Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East and Africa Protein Therapeutics Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Protein Therapeutics Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Protein Therapeutics Drugs Sales (K Dose) by Type (2019-2024)
Table 51. Global Protein Therapeutics Drugs Sales (K Dose) by Type (2025-2030)
Table 52. Global Protein Therapeutics Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Protein Therapeutics Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Protein Therapeutics Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Protein Therapeutics Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Protein Therapeutics Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Protein Therapeutics Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Protein Therapeutics Drugs Price (US$/Dose) by Type (2019-2024)
Table 59. Global Protein Therapeutics Drugs Price (US$/Dose) by Type (2025-2030)
Table 60. Global Protein Therapeutics Drugs Sales (K Dose) by Application (2019-2024)
Table 61. Global Protein Therapeutics Drugs Sales (K Dose) by Application (2025-2030)
Table 62. Global Protein Therapeutics Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Protein Therapeutics Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Protein Therapeutics Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Protein Therapeutics Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Protein Therapeutics Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Protein Therapeutics Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Protein Therapeutics Drugs Price (US$/Dose) by Application (2019-2024)
Table 69. Global Protein Therapeutics Drugs Price (US$/Dose) by Application (2025-2030)
Table 70. Johnson and Johnson Company Information
Table 71. Johnson and Johnson Description and Business Overview
Table 72. Johnson and Johnson Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Johnson and Johnson Protein Therapeutics Drugs Product
Table 74. Johnson and Johnson Recent Developments/Updates
Table 75. Pfizer Inc Company Information
Table 76. Pfizer Inc Description and Business Overview
Table 77. Pfizer Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Pfizer Inc Protein Therapeutics Drugs Product
Table 79. Pfizer Inc Recent Developments/Updates
Table 80. F. Hoffmann La Roche Ltd Company Information
Table 81. F. Hoffmann La Roche Ltd Description and Business Overview
Table 82. F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Product
Table 84. F. Hoffmann La Roche Ltd Recent Developments/Updates
Table 85. Novo Nordisk AS Company Information
Table 86. Novo Nordisk AS Description and Business Overview
Table 87. Novo Nordisk AS Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Novo Nordisk AS Protein Therapeutics Drugs Product
Table 89. Novo Nordisk AS Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Sanofi Protein Therapeutics Drugs Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Amgen Inc Company Information
Table 96. Amgen Inc Description and Business Overview
Table 97. Amgen Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Amgen Inc Protein Therapeutics Drugs Product
Table 99. Amgen Inc Recent Developments/Updates
Table 100. Merck and Co., Inc Company Information
Table 101. Merck and Co., Inc Description and Business Overview
Table 102. Merck and Co., Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Merck and Co., Inc Protein Therapeutics Drugs Product
Table 104. Merck and Co., Inc Recent Developments/Updates
Table 105. Abbott Laboratories Company Information
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Abbott Laboratories Protein Therapeutics Drugs Product
Table 109. Abbott Laboratories Recent Developments/Updates
Table 110. Baxter International Inc Company Information
Table 111. Baxter International Inc Description and Business Overview
Table 112. Baxter International Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Baxter International Inc Protein Therapeutics Drugs Product
Table 114. Baxter International Inc Recent Developments/Updates
Table 115. Eli Lilly And Company Company Information
Table 116. Eli Lilly And Company Description and Business Overview
Table 117. Eli Lilly And Company Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Eli Lilly And Company Protein Therapeutics Drugs Product
Table 119. Eli Lilly And Company Recent Developments/Updates
Table 120. AbbVie Company Information
Table 121. AbbVie Description and Business Overview
Table 122. AbbVie Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 123. AbbVie Protein Therapeutics Drugs Product
Table 124. AbbVie Recent Developments/Updates
Table 125. Novartis Company Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 128. Novartis Protein Therapeutics Drugs Product
Table 129. Novartis Recent Developments/Updates
Table 130. Gilead Sciences Company Information
Table 131. Gilead Sciences Description and Business Overview
Table 132. Gilead Sciences Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 133. Gilead Sciences Protein Therapeutics Drugs Product
Table 134. Gilead Sciences Recent Developments/Updates
Table 135. Bristol-Myers Squibb Company Information
Table 136. Bristol-Myers Squibb Description and Business Overview
Table 137. Bristol-Myers Squibb Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 138. Bristol-Myers Squibb Protein Therapeutics Drugs Product
Table 139. Bristol-Myers Squibb Recent Developments/Updates
Table 140. Innovent Company Information
Table 141. Innovent Description and Business Overview
Table 142. Innovent Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 143. Innovent Protein Therapeutics Drugs Product
Table 144. Innovent Recent Developments/Updates
Table 145. AstraZeneca Company Information
Table 146. AstraZeneca Description and Business Overview
Table 147. AstraZeneca Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 148. AstraZeneca Protein Therapeutics Drugs Product
Table 149. AstraZeneca Recent Developments/Updates
Table 150. Hengrui Medicine Company Information
Table 151. Hengrui Medicine Description and Business Overview
Table 152. Hengrui Medicine Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 153. Hengrui Medicine Protein Therapeutics Drugs Product
Table 154. Hengrui Medicine Recent Developments/Updates
Table 155. Takeda Company Information
Table 156. Takeda Description and Business Overview
Table 157. Takeda Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 158. Takeda Protein Therapeutics Drugs Product
Table 159. Takeda Recent Developments/Updates
Table 160. Kanghong Pharma Company Information
Table 161. Kanghong Pharma Description and Business Overview
Table 162. Kanghong Pharma Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 163. Kanghong Pharma Protein Therapeutics Drugs Product
Table 164. Kanghong Pharma Recent Developments/Updates
Table 165. Seagen Company Information
Table 166. Seagen Description and Business Overview
Table 167. Seagen Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 168. Seagen Protein Therapeutics Drugs Product
Table 169. Seagen Recent Developments/Updates
Table 170. Sobi Company Information
Table 171. Sobi Description and Business Overview
Table 172. Sobi Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 173. Sobi Protein Therapeutics Drugs Product
Table 174. Sobi Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Protein Therapeutics Drugs Distributors List
Table 178. Protein Therapeutics Drugs Customers List
Table 179. Protein Therapeutics Drugs Market Trends
Table 180. Protein Therapeutics Drugs Market Drivers
Table 181. Protein Therapeutics Drugs Market Challenges
Table 182. Protein Therapeutics Drugs Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Protein Therapeutics Drugs
Figure 2. Global Protein Therapeutics Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Protein Therapeutics Drugs Market Share by Type: 2023 & 2030
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Insulin Product Picture
Figure 6. Fusion Protein Product Picture
Figure 7. Erythropoietin Product Picture
Figure 8. Interferon Product Picture
Figure 9. Human Growth Hormone Product Picture
Figure 10. Others Product Picture
Figure 11. Global Protein Therapeutics Drugs Market Value by Application (2024-2030) & (US$ Million)
Figure 12. Global Protein Therapeutics Drugs Market Share by Application: 2023 & 2030
Figure 13. Cancer
Figure 14. Metabolic Disorders
Figure 15. Immunologic Disorders
Figure 16. Hematological Disorders
Figure 17. Hormonal Disorders
Figure 18. Genetic Disorders
Figure 19. Others
Figure 20. Global Protein Therapeutics Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Protein Therapeutics Drugs Market Size (2019-2030) & (US$ Million)
Figure 22. Global Protein Therapeutics Drugs Sales (2019-2030) & (K Dose)
Figure 23. Global Protein Therapeutics Drugs Average Price (US$/Dose) & (2019-2030)
Figure 24. Protein Therapeutics Drugs Report Years Considered
Figure 25. Protein Therapeutics Drugs Sales Share by Manufacturers in 2023
Figure 26. Global Protein Therapeutics Drugs Revenue Share by Manufacturers in 2023
Figure 27. Global 5 and 10 Largest Protein Therapeutics Drugs Players: Market Share by Revenue in Protein Therapeutics Drugs in 2023
Figure 28. Protein Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 29. Global Protein Therapeutics Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 30. North America Protein Therapeutics Drugs Sales Market Share by Country (2019-2030)
Figure 31. North America Protein Therapeutics Drugs Revenue Market Share by Country (2019-2030)
Figure 32. United States Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Canada Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Europe Protein Therapeutics Drugs Sales Market Share by Country (2019-2030)
Figure 35. Europe Protein Therapeutics Drugs Revenue Market Share by Country (2019-2030)
Figure 36. Germany Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. France Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. U.K. Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Italy Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Russia Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Asia Pacific Protein Therapeutics Drugs Sales Market Share by Region (2019-2030)
Figure 42. Asia Pacific Protein Therapeutics Drugs Revenue Market Share by Region (2019-2030)
Figure 43. China Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Japan Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. South Korea Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. India Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Australia Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. China Taiwan Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Southeast Asia Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Latin America Protein Therapeutics Drugs Sales Market Share by Country (2019-2030)
Figure 51. Mexico Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Colombia Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Middle East and Africa Protein Therapeutics Drugs Sales Market Share by Country (2019-2030)
Figure 56. Middle East and Africa Protein Therapeutics Drugs Revenue Market Share by Country (2019-2030)
Figure 57. Turkey Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Saudi Arabia Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. UAE Protein Therapeutics Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. Global Sales Market Share of Protein Therapeutics Drugs by Type (2019-2030)
Figure 61. Global Revenue Market Share of Protein Therapeutics Drugs by Type (2019-2030)
Figure 62. Global Protein Therapeutics Drugs Price (US$/Dose) by Type (2019-2030)
Figure 63. Global Sales Market Share of Protein Therapeutics Drugs by Application (2019-2030)
Figure 64. Global Revenue Market Share of Protein Therapeutics Drugs by Application (2019-2030)
Figure 65. Global Protein Therapeutics Drugs Price (US$/Dose) by Application (2019-2030)
Figure 66. Protein Therapeutics Drugs Value Chain
Figure 67. Protein Therapeutics Drugs Production Process
Figure 68. Channels of Distribution (Direct Vs Distribution)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
